Literature DB >> 24006219

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with a central and peripheral carcinoid and multiple tumorlets: a case report emphasizing the role of neuropeptide hormones and human gonadotropin-alpha.

Hanako Oba1, Kazunori Nishida, Shingo Takeuchi, Hirohiko Akiyama, Koji Muramatsu, Masafumi Kurosumi, Toru Kameya.   

Abstract

We report a case of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). We performed immunohistochemical analysis of 17 neuropeptides and human gonadotropin-alpha (hCGα), a trophoblastic peptide that promotes the proliferation of neuroendocrine cells. A 51-year-old woman with no history of smoking was found to have a nodule in the right middle lobe. Upon examination, the nodule was found to comprise diffuse linear and nodular neuroendocrine cell hyperplasia (NECH), numerous pulmonary tumorlets merging with one peripheral carcinoid, and an additional central carcinoid. Immunohistochemical analysis revealed diffuse but intense expression of the general neuroendocrine markers CD56, synaptophysin, and chromogranin A, together with gastrin-releasing peptide (GRP), calcitonin, and hCGα throughout the carcinoids, tumorlets, and NECH. Positive staining was also noted for adrenocorticotropic hormone, corticotropin-releasing hormone, met-enkephalin, vasoactive intestinal polypeptide, neurotensin, and growth hormone-releasing hormone in a few isolated cells of the carcinoids and the tumorlets, but staining for these proteins was entirely negative in the NECH lesions. The presence of these neuropeptides in neuroendocrine tumors might explain the presence of neuropeptide-producing tumors of the lungs, cases of which have been reported over the last 30 years. The preoperative serum proGRP level was high but returned to normal after surgical intervention, indicating that GRP was produced and secreted by carcinoids, tumorlets, and/or NECH lesions. It is also probable that neuroendocrine cells secreted GRP into the interstitium in a paracrine manner, leading to the development of dense fibrosis around the tumorlets. During the preoperative and postoperative periods, no evidence of bronchiolitis obliterans was noted, in contrast to some previously reported cases of DIPNECH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006219     DOI: 10.1007/s12022-013-9265-8

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  43 in total

1.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia as a precursor to pulmonary neuroendocrine tumors.

Authors:  John R Gosney
Journal:  Chest       Date:  2004-05       Impact factor: 9.410

2.  Unilateral diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and multiple carcinoids treated with surgical resection.

Authors:  Sheeba Irshad; Emma McLean; Sheila Rankin; Sally Barrington; George Santis; James Spicer; Loic Lang-Lazdunski
Journal:  J Thorac Oncol       Date:  2010-06       Impact factor: 15.609

3.  [EGFR-expression in pulmonary neuroendocrine cell hyperplasia].

Authors:  C Kuhnen; B U Winter
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

4.  Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma.

Authors:  S M Aguayo; T E King; J A Waldron; K M Sherritt; M A Kane; Y E Miller
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

5.  Diffuse idiopathic neuroendocrine cell hyperplasia causing severe airway obstruction in a patient with a carcinoid tumor.

Authors:  Heiner Adams; Thomas Brack; Peter Kestenholz; Peter Vogt; Hans C Steinert; Erich W Russi
Journal:  Respiration       Date:  2005-08-30       Impact factor: 3.580

6.  Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens: analysis of 28 patients.

Authors:  Marie-Christine Aubry; Charles F Thomas; James R Jett; Stephen J Swensen; Jeffrey L Myers
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

7.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.

Authors:  Susan J Davies; John R Gosney; David M Hansell; Athol U Wells; Roland M du Bois; Margaret M Burke; Mary N Sheppard; Andrew G Nicholson
Journal:  Thorax       Date:  2006-11-10       Impact factor: 9.139

8.  Peripheral lung carcinoid tumor producing predominantly gastrin-releasing peptide (GRP). Morphologic and hormonal studies.

Authors:  S Tamai; T Kameya; K Yamaguchi; N Yanai; K Abe; N Yanaihara; H Yamazaki; K Kageyama
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

9.  Pulmonary Neuroendocrine Cells and Lung Development.

Authors:  Mary E. Sunday
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

10.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia accompanied by airflow obstruction.

Authors:  Ester Nei Aparecida Martins Coletta; Larissa Rêgo Voss; Mariana Silva Lima; Jaquelina Sonoe Ota Arakaki; Juvêncio Câmara; Carlos D'Andretta Neto; Carlos Alberto de Castro Pereira
Journal:  J Bras Pneumol       Date:  2009-05       Impact factor: 2.624

View more
  2 in total

Review 1.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.

Authors:  Eric Wirtschafter; Ann E Walts; Sandy T Liu; Alberto M Marchevsky
Journal:  Lung       Date:  2015-06-24       Impact factor: 2.584

2.  Medullary carcinoma of the thyroid metastatic to the breast: a case report and literature review.

Authors:  Sebastião Nunes Martins; Marcelo Abrantes Giannotti; Sheila Aparecida Coelho Siqueira
Journal:  Autops Case Rep       Date:  2014-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.